AIRLINK 177.90 Decreased By ▼ -18.75 (-9.53%)
BOP 10.15 Increased By ▲ 0.01 (0.1%)
CNERGY 6.60 Decreased By ▼ -0.09 (-1.35%)
FCCL 33.09 Increased By ▲ 0.07 (0.21%)
FFL 16.25 Decreased By ▼ -0.40 (-2.4%)
FLYNG 22.45 No Change ▼ 0.00 (0%)
HUBC 125.77 Decreased By ▼ -1.52 (-1.19%)
HUMNL 13.81 Decreased By ▼ -0.09 (-0.65%)
KEL 4.76 No Change ▼ 0.00 (0%)
KOSM 6.37 No Change ▼ 0.00 (0%)
MLCF 42.40 Increased By ▲ 0.18 (0.43%)
OGDC 210.00 Decreased By ▼ -3.03 (-1.42%)
PACE 6.88 Decreased By ▼ -0.13 (-1.85%)
PAEL 40.25 Decreased By ▼ -0.62 (-1.52%)
PIAHCLA 17.33 Increased By ▲ 0.51 (3.03%)
PIBTL 8.30 Increased By ▲ 0.01 (0.12%)
POWER 8.85 Increased By ▲ 0.03 (0.34%)
PPL 181.50 Decreased By ▼ -2.07 (-1.13%)
PRL 37.55 Decreased By ▼ -0.72 (-1.88%)
PTC 24.10 Increased By ▲ 0.03 (0.12%)
SEARL 94.90 Decreased By ▼ -0.21 (-0.22%)
SILK 1.00 No Change ▼ 0.00 (0%)
SSGC 39.70 Decreased By ▼ -0.61 (-1.51%)
SYM 17.83 Decreased By ▼ -0.38 (-2.09%)
TELE 8.63 Decreased By ▼ -0.10 (-1.15%)
TPLP 12.45 Increased By ▲ 0.24 (1.97%)
TRG 63.65 Decreased By ▼ -0.71 (-1.1%)
WAVESAPP 10.36 Decreased By ▼ -0.08 (-0.77%)
WTL 1.76 Decreased By ▼ -0.03 (-1.68%)
YOUW 4.05 Increased By ▲ 0.05 (1.25%)
BR100 11,654 Decreased By -69.2 (-0.59%)
BR30 34,961 Decreased By -398.3 (-1.13%)
KSE100 112,358 Decreased By -280.2 (-0.25%)
KSE30 35,314 Decreased By -143.6 (-0.4%)

void(0)" onMouseOver="popup(event,'Copyright Business Recorder, 2014

No content from Business Recorder shall be reproduced, published, broadcast, rewritten for broadcast or publication, or redistributed directly or indirectly in any medium.
Business Recorder shall not be responsible or held liable for any error of fact, opinion or recommendation and also for any loss, financial or otherwise, resulting from business or trade or speculation conducted, or investments made, on the basis of the information posted here. Nor shall Business Recorder be held liable for any actions taken in consequence.')" onMouseOut="popop(event,'tip1')" style="cursor:pointer">Copyright Business Recorder, 2014

Comments

Comments are closed.